20.59
0.49%
0.10
Dopo l'orario di chiusura:
20.59
Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
4.24%
79.86
|
83.39 | 67.05 | 71.47 | 48.34 |
Cost Of Revenue |
10.58
|
- | 9.088 | 7.699 | 7.036 |
Gross Profit |
69.28
|
- | 57.96 | 63.77 | 41.31 |
Operating Expenses
|
19.90%
85.82
|
107.14 | 68.89 | 66.93 | 59.54 |
Benefits Costs and Expenses |
16.29%
94.13
|
80.94 | 75.55 | 72.71 | 57.71 |
Costs And Expenses |
16.29%
94.13
|
80.94 | 75.55 | 72.71 | 57.71 |
Depreciation and Amortization |
13.70%
0.466
|
0.54 | 0.603 | 0.602 | 0.596 |
Operating Income/Loss |
20,522%
-16.54
|
0.081 | -10.93 | -3.154 | -11.20 |
Income/Loss From Continuing Operations Before Tax |
682.69%
-14.28
|
2.45 | -8.499 | -1.239 | -9.364 |
Income Tax Expense/Benefit, Deferred |
116.98%
4.365
|
-25.71 | 10.29 | -19.44 | 1.077 |
Income Tax Expense/Benefit |
115.04%
3.428
|
-22.79 | 5.356 | -16.21 | 2.906 |
Income/Loss From Continuing Operations After Tax |
170.15%
-17.70
|
25.24 | -13.86 | 14.97 | -12.27 |
Net Income/Loss
|
170.15%
-17.70
|
25.24 | -13.86 | 14.97 | -12.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
66,939%
70.63
|
0.1054 | 70.19 | 69.92 | 69.75 |
Diluted Average Shares |
3,487%
70.63
|
1.9693 | 70.19 | 71.63 | 69.75 |
Basic Earnings Per Share |
169.44%
-0.25
|
0.36 | -0.20 | 0.21 | -0.18 |
Diluted Earnings Per Share |
169.44%
-0.25
|
0.36 | -0.20 | 0.21 | -0.18 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):